Childhood cancers trials in United States
930 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleStudies on Tumors of the Thyroid
- Where
- Bethesda
- Age
- 6 months to 98 years
- People
- 2,500
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00001160 - No phaseTaking peoplePsychological Benefits of a Normalized Camping Experience for Children With Cancer
- Where
- Bethesda
- Age
- 7 years to 25 years
- People
- 5,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00001186 - No phaseEnrolling by invitationScreening for Hematology Branch Protocols
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 10,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00001620 - No phaseTaking peopleCollection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- Where
- Bethesda
- Age
- 2 years and over
- People
- 5,950
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00026884 - No phaseTaking peopleCancer in Inherited Bone Marrow Failure Syndromes
- Where
- Bethesda, Rockville
- Age
- 1 day to 100 years
- People
- 4,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00027274 - No phaseTaking peopleGenetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
- Where
- Bethesda
- Age
- 2 years and over
- People
- 950
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00033137 - No phaseTaking peopleClinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
- Where
- Bethesda
- Age
- 7 years to 90 years
- People
- 500
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT01109420 - No phaseTaking peopleDICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
- Where
- Bethesda, Rockville
- Age
- 1 month to 99 years
- People
- 1,500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01247597 - No phaseTaking peopleClinical and Genetic Studies of Li-Fraumeni Syndrome
- Where
- Bethesda
- People
- 5,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01443468 - No phaseEnrolling by invitationFollow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
- Where
- Bethesda
- Age
- 1 year to 99 years
- People
- 500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02315599 - No phaseTaking peopleGenomic Services Research Program
- Where
- Bethesda
- Age
- 1 month to 105 years
- People
- 5,000
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT02595957 - No phaseTaking peopleTumor Related Epilepsy
- Where
- Bethesda
- Age
- 8 years to 99 years
- People
- 100
- Run by
- National Institute of Neurological Disorders and Stroke (NINDS)
See details and how to joinNCT02639325 - No phaseEnrolling by invitationLeukapheresis for CAR or Adoptive Cell Therapy Manufacturing
- Where
- Bethesda
- Age
- 3 years to 65 years
- People
- 120
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03226704 - No phaseTaking peopleBiospecimen Procurement for Head and Neck Disorders
- Where
- Baltimore, Bethesda, Washington D.C.
- Age
- 3 years to 120 years
- People
- 1,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03429036 - No phaseTaking peopleNatural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
- Where
- Bethesda, Houston, Portland
- Age
- 4 weeks and over
- People
- 10,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03739827 - No phaseTaking peopleChildren and Adults With Chordoma
- Where
- Bethesda
- Age
- 2 years and over
- People
- 300
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03910465 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- Where
- Atlanta, Beverly Hills, Denver, Houston
- Age
- 12 years and over
- People
- 276 worldwide
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT04192344 - Phase 1Taking peopleMetarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Where
- Bethesda, Fairway
- Age
- 12 years to 120 years
- People
- 116
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04222413 - No phaseTaking peopleSurgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
- Where
- Bethesda
- Age
- 6 years and over
- People
- 400
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04557969 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Ann Arbor, Cincinnati, Dallas, Houston, Milwaukee, New York, Portland, Salt Lake City, St Louis
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peoplePhase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Where
- Bethesda, Philadelphia
- Age
- 12 years to 85 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04959175 - No phaseTaking peopleCognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- Where
- Bethesda, Los Angeles, Seattle
- Age
- 5 years and over
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05237986 - Phase 1/2Taking peopleDonor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 430
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05327023 - Phase 1/2Taking peopleTrial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 265
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05470491 - Phase 2Taking peopleA Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- People
- 100
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06057948